A novel tissue treatment to reduce mineralization of bovine pericardial heart valves
- PMID: 29572021
- DOI: 10.1016/j.jtcvs.2018.01.099
A novel tissue treatment to reduce mineralization of bovine pericardial heart valves
Abstract
Objective: With the increasing use of bioprostheses worldwide, continuous efforts have been made to improve tissue durability. We introduce a new treatment for bovine pericardium combining octanediol-ethanol based phospholipid removal with taurine-based glutaraldehyde neutralization and storage in an aldehyde-free solution (FREE).
Methods: Treated tissues were evaluated by mechanical and biochemical characterization, phospholipid content, aldehyde levels, cell cultures on pericardial samples (L929 fibroblasts and human umbilical vein endothelial cells), rat subcutaneous implantations, and long-term juvenile sheep mitral valve implantations (n = 3). Comparisons were made to glutaraldehyde-fixed bovine pericardium or to samples from commercially available biological valves (ie, Trifecta [St Jude Medical, Saint Paul, Minn] and Perimount Magna Ease [Edwards Lifesciences, Irvine, Calif]).
Results: FREE-treated pericardium had similar mechanical strength and biochemical properties as commercially available valves. Compared with glutaraldehyde-only samples, FREE-treated samples showed lower phospholipid levels (P < .01), significantly better growth of L929 fibroblasts, and lower calcification levels in rat subcutaneous implants (P < .01). Compared with samples from Linx- (Trifecta) and ThermaFix-treated (Perimount Magna Ease) valves, similar low levels of phospholipids were observed as were similar low calcification levels in subcutaneous implants, but tissue extractions from FREE-treated samples showed the lowest levels of extracted aldehydes (P < .01). Mitral implants of FREE-treated valves in juvenile sheep had excellent hemodynamic behavior without any sign of degeneration or calcification at 5 months.
Conclusions: The new FREE treatment combines an adequate phospholipid reduction and aldehyde neutralization with storage in an aldehyde-free solution. This combination enhances the anticalcification properties and may thereby improve long-term durability of the tissue.
Keywords: anticalcification treatment; durability; heart valves.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Comment in
-
A heart valve is no stronger than its weakest link: The need to improve durability of pericardial leaflets.J Thorac Cardiovasc Surg. 2018 Jul;156(1):207-208. doi: 10.1016/j.jtcvs.2018.03.034. Epub 2018 Mar 17. J Thorac Cardiovasc Surg. 2018. PMID: 29636190 Free PMC article.
-
The pursuit of optimal tissue valve durability: Novel treatments.J Thorac Cardiovasc Surg. 2018 Jul;156(1):196. doi: 10.1016/j.jtcvs.2018.04.059. Epub 2018 Apr 21. J Thorac Cardiovasc Surg. 2018. PMID: 29921094 No abstract available.
Similar articles
-
The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.J Heart Valve Dis. 2016 Mar;25(2):253-261. J Heart Valve Dis. 2016. PMID: 27989076
-
Advanced Integrity Preservation Technology Reduces Bioprosthesis Calcification While Preserving Performance and Safety.J Heart Valve Dis. 2015 Jan;24(1):101-9. J Heart Valve Dis. 2015. PMID: 26182627
-
Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.Eur J Cardiothorac Surg. 2008 Aug;34(2):418-22. doi: 10.1016/j.ejcts.2008.05.012. Epub 2008 Jun 11. Eur J Cardiothorac Surg. 2008. PMID: 18550382
-
Prevention of calcification in bioprosthetic heart valves: challenges and perspectives.Expert Opin Biol Ther. 2004 Dec;4(12):1971-85. doi: 10.1517/14712598.4.12.1971. Expert Opin Biol Ther. 2004. PMID: 15571459 Review.
-
A novel anticalcification treatment strategy for bioprosthetic valves and review of the literature.J Card Surg. 2019 Oct;34(10):895-900. doi: 10.1111/jocs.14151. Epub 2019 Jul 3. J Card Surg. 2019. PMID: 31269321 Review.
Cited by
-
Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.Front Bioeng Biotechnol. 2022 Aug 4;10:920152. doi: 10.3389/fbioe.2022.920152. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35992331 Free PMC article. Review.
-
A glimpse of hope: cardiac surgery in low- and middle-income countries (LMICs).Cardiovasc Diagn Ther. 2020 Apr;10(2):336-349. doi: 10.21037/cdt.2019.11.03. Cardiovasc Diagn Ther. 2020. PMID: 32420116 Free PMC article. Review.
-
Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective.Braz J Cardiovasc Surg. 2022 May 2;37(2):239-250. doi: 10.21470/1678-9741-2020-0635. Braz J Cardiovasc Surg. 2022. PMID: 34673516 Free PMC article. Review.
-
Clinical and hemodynamic outcomes of the Perceval sutureless aortic valve from a real-world registry.Interdiscip Cardiovasc Thorac Surg. 2023 Jun 1;36(6):ivad103. doi: 10.1093/icvts/ivad103. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37307090 Free PMC article.
-
Free-aldehyde neutralized and oligohyaluronan loaded bovine pericardium with improved anti-calcification and endothelialization for bioprosthetic heart valves.Front Bioeng Biotechnol. 2023 Apr 3;11:1138972. doi: 10.3389/fbioe.2023.1138972. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37077226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources